title: Long-term results following pars plana vitrectomy with platelet concentrate in pediatric patients with traumatic macular hole.
abstract: OBJECTIVE
  To describe the long-term clinical course in children with a traumatic macular hole after vitrectomy with platelet concentrate.
  
  
  METHODS
  Interventional case series.
  
  
  METHODS
  Four pediatric patients with a mean age of 13.2 years (range, 10-15 years) underwent pars plana vitrectomy with platelet concentrate, internal limiting membrane peeling, and SF6 gas tamponade for stage 3 traumatic macular hole repair.
  
  
  RESULTS
  Primary closure was achieved by a single intervention in all patients with a marked visual improvement of three to seven lines after surgery. The surgically achieved visual improvement remained stable and no vision-threatening complications occurred during the mean follow up of 35.2 months (range, 27-51 months).
  
  
  CONCLUSIONS
  We regard pars plana vitrectomy with platelet concentrate and SF6 gas instillation as safe and effective and, therefore, as the therapy of choice for traumatic macular holes particularly in children after a period of observation no longer than 3 to 4 months.
authors.affiliation: Department of Ophthalmology, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Berlin, Germany. wachtlin@ukbf.fu-berlin.de
authors.forename: Joachim
authors.initials: J
authors.lastname: Wachtlin
authors.forename: Claudia
authors.initials: C
authors.lastname: Jandeck
authors.forename: Simone
authors.initials: S
authors.lastname: Potthöfer
authors.forename: Ulrich
authors.initials: U
authors.lastname: Kellner
authors.forename: Michael H
authors.initials: MH
authors.lastname: Foerster
mesh_terms: D000293:Adolescent; D001792:Blood Platelets; D002648:Child; D003131:Combined Modality Therapy; D019773:Epiretinal Membrane / Q000601:surgery; D005131:Eye Injuries / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D008266:Macula Lutea / Q000293:injuries*; D008297:Male; D012167:Retinal Perforations / Q000628:therapy*; D012449:Safety; D013459:Sulfur Hexafluoride / Q000008:administration & dosage; D016896:Treatment Outcome; D014792:Visual Acuity; D014821:Vitrectomy / Q000379:methods*; D014949:Wounds, Nonpenetrating / Q000628:therapy*
chemical_list: D013459:Sulfur Hexafluoride